You searched for Antibody candidate - Page 10 of 69

News and Trends 4 Jul 2016

Novartis delivers German Biotech’s 12th Antibody to Clinics

MorphoSys keeps up its impressive productivity in feeding pipelines. Its 12th antibody in its Novartis collaboration has just reached clinical development. After presenting results for two of its wholly-owned candidates…

July 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2017

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

Apogenix’ partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the potential to outperform antibody therapy. The German biotech Apogenix has announced that its partner AbbVie…

April 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jun 2025

ASCO 2025: key highlights in cancer therapeutics

…candidate is also in the clinic for cervical cancer. Another clinical-stage biotech that unveiled data from its cancer immunotherapy trial is Paris-based Enterome. Its candidate EO4010 is made up of…

June 4, 2025 - 18 minutesmins - By Roohi Mariam Peter

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

…competitors, BMS, MSD and Roche, in the coveted PD-L1 / PD-1 checkpoint inhibitor space. The Danish antibody giant Genmab presented a Phase I/IIa update on HuMax-AXL-ADC, an antibody-drug conjugate (ADC)…

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 20 Dec 2021

The Billion-Euro European Biotech Companies in 2022

…of antibody treatments for cancer and inflammatory and autoimmune diseases. Its first antibody, Tremfya, a treatment for psoriasis, was launched in 2017 in collaboration with Janssen. The company has ongoing…

December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 20 Nov 2023

M&As: what’s up with the ADC buying spree?

…biotech Orum Therapeutics’ ADC candidate is proof of this. The anti-CD33 antibody-enabled GSPT1 degrader, ORM-6151, received U.S. Food and Drug Administration (FDA) clearance to pursue phase 1 trials for treating…

November 20, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 6 Jun 2017

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

…Pharma has in-licensed a new clinical-stage antibody candidate from Novo Nordisk to reinforce its position in the crowded space. In exchange for its anti-C5aR antibody, IPH5401, Novo Nordisk gets a…

June 6, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 29 Oct 2019

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

…target of the drug, and MorphoSys, which generated antibody candidates for the target. Several months after the pair reported positive phase I results last year, Novartis licensed the drug in…

October 29, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

…solid tumors. The drug is a monoclonal antibody, which is a type of protein that can bind to antigens of cancer cells; flagging the cells and could trigger the destruction…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 18 Dec 2017

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

…results. Its candidate, ABX464, caused a significant reduction of viral reservoirs over a 28-day period. The study included just 11 patients, with 9 completing the study and 8 of those…

December 18, 2017 - 9 minutesmins - By Alex Dale

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…a pipeline of immune-enabling therapies and vaccines for life-threatening bacterial infections associated with biofilms, with a near-term focus on challenging respiratory infections. Clarametyx’s lead candidate is an immune-enabling antibody therapy…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 30 Nov 2023

Could an Alzheimer’s vaccine make treatment more affordable?

…Reuters report, AC Immune is challenging this rhetoric. The Swiss company’s phase 1/2 ABATE trial is testing its Alzheimer’s vaccine candidate ACI-24.060 in patients with Down’s syndrome. The candidate is…

November 30, 2023 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Novartis delivers German Biotech’s 12th Antibody to Clinics

Next-Gen Cancer Antibody Technology from Germany enters the Clinic

ASCO 2025: key highlights in cancer therapeutics

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

The Billion-Euro European Biotech Companies in 2022

M&As: what’s up with the ADC buying spree?

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

MorphoSys and Galapagos’ Eczema Drug Abandoned at Phase II

10 immunotherapy companies making waves in 2023

Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017

6 biotech companies tackling antibiotic resistance

Could an Alzheimer’s vaccine make treatment more affordable?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!